Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hair follicle systems are being engineered to better mimic natural hair follicles for studying hair disorders and testing treatments.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Hair follicles in nonsegmental vitiligo are better protected from immune attacks than in alopecia areata.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

Restoring hair follicle immune privilege may help treat alopecia areata.

EGFR inhibitors cause skin issues and hair loss by weakening skin defenses, suggesting antibiotics and targeted treatments can help.

Gasdermin A3 causes hair follicle stem cells to activate too early, leading to hair loss.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Alopecia areata patients should have eye check-ups due to increased risk of eye problems.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

New treatments for alopecia areata show promise but need ongoing use and have infection risks.

The role of antibodies in alopecia is unclear, but JAK inhibitors show promise for treatment.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Statins may help treat alopecia areata by reducing harmful immune interactions.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Alopecia areata patients have a higher risk of retinal issues, but routine eye checks should be symptom-based.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.